Basal cell carcinoma (BCC) is the most common cancer worldwide, with its incidence doubling over the past 20 years. Traditional treatments, primarily surgical excision, come with a recurrence risk and potential complications. This article explores the potential of Talimogene laherparepvec (T-VEC),
A significant breakthrough in vaccine development has been achieved by a collaboration between the Ragon Institute and the Jameel Clinic at MIT, as they unveil MUNIS, a deep learning tool designed to accurately predict CD8+ T cell epitopes. This innovative tool promises to accelerate vaccine
In the relentless pursuit of enhanced cancer treatments, recent research has shed light on the dual inhibition of MYCN and MDM2 as a promising strategy. Both MYCN and MDM2 are vital oncogenes implicated in various tumorigenic processes. Their simultaneous targeting might revolutionize the
Tuberculosis (TB) remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant challenge to global health. Recent advancements in TB treatment, particularly for drug-resistant forms, offer new hope. This article explores the potential of new drug
New research shines light on position-specific hallmarks of cancer, diving deeply into the contemporary understanding of cancer and focusing on the specific expression patterns of cancer hallmarks within tumors. The fundamental question it addresses is, "What is a tumor?"—a crucial query w
Imagine a future where birth injuries, facial defects, and other cartilage-related conditions could be treated effectively and efficiently with a novel tissue that combines softness, elasticity, and stability. This future has moved significantly closer to reality with the discovery of a new
